Keyphrases
Ischemia-reperfusion Injury
100%
Cardiomyocytes
100%
Acute Phase
100%
Fibroblast Growth Factor Receptor Signaling
100%
Phase Following
100%
Fibroblast Growth Factor Receptor 1 (FGFR1)
75%
Cardiac Ischemia-reperfusion Injury
50%
Reperfusion
37%
FGF Ligand
25%
Cardioprotection
25%
Protective Behavior
25%
Fibroblast Growth Factor Receptor 2 (FGFR2)
25%
Adult Mice
12%
Improved Outcomes
12%
Ischemia
12%
Infarct
12%
Multiple Cell Types
12%
Study Support
12%
Cardiac Hypertrophy
12%
Infarct Size
12%
Cross-sectional Area
12%
Myocytes
12%
Non-cell Autonomous
12%
Cardiac Function
12%
Therapeutic Strategies
12%
Vascular Remodeling
12%
Vessel Density
12%
Adult Heart
12%
Cardiac Remodeling
12%
Genetic Parameters
12%
Cardiac Dysfunction
12%
Endogenous Cells
12%
Area Density
12%
Transient Activation
12%
FGF Signaling
12%
Adult Cardiomyocytes
12%
Cardiac Morphometry
12%
Medicine and Dentistry
Reperfusion Injury
100%
Cardiac Muscle Cell
100%
Fibroblast Growth Factor Receptor
100%
Heart Muscle Ischemia
44%
Muscle Cell
22%
Fibroblast Growth Factor Receptor 1
22%
Injury
11%
Infarction
11%
Ischemia
11%
Heart Ventricle Remodeling
11%
Morphometrics
11%
Heart Protection
11%
Vascular Remodeling
11%
Heart Infarction Size
11%
Biochemistry, Genetics and Molecular Biology
Fibroblast Growth Factor Receptor
100%
Reperfusion
100%
Cardiac Muscle Cell
100%
Fibroblast Growth Factor Receptor 1
16%
Genotyping
8%
Heart Size
8%
Pharmacology, Toxicology and Pharmaceutical Science
Reperfusion Injury
100%
Fibroblast Growth Factor Receptor
100%
Heart Muscle Ischemia
44%
Fibroblast Growth Factor Receptor 1
22%
Injury
11%
Infarction
11%
Ischemia
11%
Vascular Remodeling
11%
Heart Ventricle Remodeling
11%
Heart Infarction Size
11%